Goodbody Health Inc
OTC:GDBYF
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
G
|
Goodbody Health Inc
OTC:GDBYF
|
27.9k USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
989.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
573.4B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
281.1B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
302.9B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
230.9B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.1B GBP |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.3B USD |
Loading...
|
Market Distribution
| Min | -9 940 586.9% |
| 30th Percentile | -85.9% |
| Median | -7.8% |
| 70th Percentile | 5.5% |
| Max | 60 777.6% |
Other Profitability Ratios
Goodbody Health Inc
Glance View
Goodbody Health, Inc. operates as a health and wellness company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-09-21. The firm operates both in wellness testing in the United Kingdom and as a vertically integrated cannabinoid (CBD) company that operates in the United Kingdom and the European Union. The company operates under one segment: the sale of cannabinoid products and clinic and cannabinoid testing. The firm focuses on offering COVID and blood testing clinics, CBD extraction, wholesale bulk isolate and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs. The company provides a local level network of approximately 140 clinics, providing over 30 blood and polymerase chain reaction (PCR) tests for at home or in clinic testing. The Company’s subsidiaries include Borganic, Olimax, Olimax RE, Sativa Wellness Group Poland, Sativa Group, Goodbody Botanicals and Phytovista Laboratories.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
Over the last 11 months, Goodbody Health Inc’s Net Margin has increased from -90.3% to -7.3%. During this period, it reached a low of -90.3% on May 30, 2021 and a high of -7.3% on May 1, 2022.
